The Emerging Physiological Role of AGMO 10 Years after Its Gene Identification
The gene encoding alkylglycerol monooxygenase (AGMO) was assigned 10 years ago. So far, AGMO is the only known enzyme capable of catalysing the breakdown of alkylglycerols and lyso-alkylglycerophospholipids. With the knowledge of the genetic information, it was possible to relate a potential contrib...
Main Authors: | Sabrina Sailer, Markus A. Keller, Ernst R. Werner, Katrin Watschinger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/2/88 |
Similar Items
-
AGMO Inhibitor Reduces 3T3-L1 Adipogenesis
by: Caroline Fischer, et al.
Published: (2021-05-01) -
Oral Supplementation of an Alkylglycerol Mix Comprising Different Alkyl Chains Effectively Modulates Multiple Endogenous Plasmalogen Species in Mice
by: Sudip Paul, et al.
Published: (2021-05-01) -
Multiple Shades of Gray—Macrophages in Acute Allograft Rejection
by: Katharina Lackner, et al.
Published: (2023-05-01) -
Maximal dietary responsiveness after tetrahydrobiopterin (BH4) in 19 phenylalanine hydroxylase deficiency patients: What super-responders can expect
by: Jariya Upadia, et al.
Published: (2024-03-01) -
Plasmalogen Replacement Therapy
by: José Carlos Bozelli, et al.
Published: (2021-10-01)